Cargando…
Association of β-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion
There are limited data regarding the efficacy of β-blockers for secondary prevention in patients with coronary chronic total occlusion (CTO). Therefore, we investigated the association of β-blocker therapy with long-term clinical outcomes in CTO patients. From March 2003 to February 2012, a total of...
Autores principales: | Hwang, Jin Kyung, Yang, Jeong Hoon, Hwang, Ji-won, Jang, Woo Jin, Song, Young Bin, Hahn, Joo-Yong, Choi, Jin-Ho, Lee, Sang Hoon, Gwon, Hyeon-Cheol, Choi, Seung-Hyuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265841/ https://www.ncbi.nlm.nih.gov/pubmed/27472704 http://dx.doi.org/10.1097/MD.0000000000004300 |
Ejemplares similares
-
Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion
por: Lee, Seung Hwa, et al.
Publicado: (2017) -
Long-term Survival Benefit of Statin in Patients with Coronary Chronic Total Occlusion without Revascularization
por: Kim, Bum Sung, et al.
Publicado: (2018) -
Sustained beneficial effect of β-blockers on clinical outcomes after discontinuation in patients with ST elevation myocardial infarction
por: Park, Jin-Sun, et al.
Publicado: (2023) -
Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10‐Year Follow‐Up Study
por: Park, Taek Kyu, et al.
Publicado: (2021) -
First-Generation Versus Second-Generation Drug-Eluting Stents in Coronary Chronic Total Occlusions: Two-Year Results of a Multicenter Registry
por: Ahn, Jong-Hwa, et al.
Publicado: (2016)